| Dr Lensey Crashun Scott, MD | |
|
525 Western Ave Ste 202, Conway, AR 72034-4980 | |
| (501) 513-5337 | |
| Not Available |
| Full Name | Dr Lensey Crashun Scott |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 525 Western Ave Ste 202, Conway, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225126626 | NPI | - | NPPES |
| 212259001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | E-9401 (Arkansas) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | E-9401 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Medical Center- Conway | Conway, AR | Hospital |
| Baptist Health Medical Center-little Rock | Little rock, AR | Hospital |
| Conway Regional Health System | Conway, AR | Hospital |
| Baptist Health Medical Center Heber Spings | Heber springs, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health | 0648177949 | 71 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578593067 PECOS PAC ID: 0648177949 Enrollment ID: O20031215000977 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | South Arkansas Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427018704 PECOS PAC ID: 0749273670 Enrollment ID: O20040406001623 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | St Marys Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124084991 PECOS PAC ID: 4981698032 Enrollment ID: O20040609000759 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Arkansas Health Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932118890 PECOS PAC ID: 7911802079 Enrollment ID: O20040726000650 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Baptist Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316210875 PECOS PAC ID: 0648177949 Enrollment ID: O20120320000778 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Southeast Arkansas Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912374018 PECOS PAC ID: 9537479605 Enrollment ID: O20151103000750 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Ess Of El Dorado, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861851131 PECOS PAC ID: 8325345432 Enrollment ID: O20160404001667 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Conway Community Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275084188 PECOS PAC ID: 3971895137 Enrollment ID: O20170308000505 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Entity Name | Hcc Of El Dorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003578725 PECOS PAC ID: 1850789488 Enrollment ID: O20211101000418 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lensey Crashun Scott, MD 525 Western Ave, Suite 202, Conway, AR 72034-4967 Ph: (501) 513-5337 | Dr Lensey Crashun Scott, MD 525 Western Ave Ste 202, Conway, AR 72034-4980 Ph: (501) 513-5337 |
News Archive
Translational Sciences Corporation (TSC) announced today that it has received FDA 510(k) clearance for commercialization of its OncoTrac medical imaging software.
The U.S. Food and Drug Administration today approved Zytiga in combination with prednisone to treat patients with late-stage castration-resistant prostate cancer who have received prior docetaxel.
A recent report from the World Health Organization set off alarm bells for many expectant parents. The report showed that newborns in 40 countries, including Cuba, South Korea and Poland, have a lower risk of death than newborns in the United States.
Those looking to leave the workforce before age 65 but worried about losing their health coverage may feel freer to retire thanks to the health law, a new report concludes.
› Verified 9 days ago
Gregory Allen Kendrick, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 437 Denison St, Conway, AR 72034 Phone: 501-327-1325 Fax: 501-327-1328 | |
Dr. Meryem Maras-casey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 605 Salem Rd Ste B3, Conway, AR 72034 Phone: 501-585-3935 Fax: 501-585-2955 | |
Dr. Anvitha Reddy Ankireddypalli, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 650 United Dr Ste 240, Conway, AR 72032 Phone: 501-329-1415 | |
Dr. Hooman Motahari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Western Ave Ste 305b, Conway, AR 72034 Phone: 501-205-4990 Fax: 501-205-4993 | |
Mina Michael Kamel Michael, Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1355 Dave Ward Dr Ste 102, Conway, AR 72034 Phone: 346-907-4805 | |
Arthur Reed Slaton, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Altus St, Conway, AR 72032 Phone: 501-513-5909 Fax: 501-513-5257 | |
Swetha Boddeda, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 Western Ave Ste 305a, Conway, AR 72034 Phone: 501-358-6145 Fax: 501-504-6642 |